Original Source(s)
Related Content
FDA Approves Melanoma BRAF Companion Test
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
August 10, 2026
-
1 min
Hidden Pitfalls in MET Exon 14 Testing
Large cohort study examines limitations of DNA- and RNA-based sequencing in routine diagnostics
August 17, 2026
-
3 min
A Mother's Search for Answers
How one family's experience is helping improve awareness, research, and care for people living with rare diseases
August 19, 2026
-
7 min